Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Antonio, TX
NPI
1316904139
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5107 Medical Dr
San Antonio, TX, 78229
Phone (210) 614-8612
Groups this clinician bills Medicare through
Medicare paid, 2024
$582K
21,608 services
Medicare patients, 2024
988
Average age 73
Drug cost, 2024
$2.9M
6,751 prescriptions
Company payments, 2025
$7,093
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacob Vadakekalam was code 36415 (venipuncture blood collection), 2,102 times for 897 patients. In total Jacob Vadakekalam billed 21,608 services in 93 codes, and Medicare paid $582K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 2,102 | 897 | $5.85 | $12K |
| 99214 Office E&M - Established | Office | 2,024 | 811 | $86.52 | $175K |
| 80053 Clinical Chemistry | Office | 1,737 | 812 | $10.27 | $18K |
| 83036 Blood Count | Office | 1,534 | 707 | $9.41 | $14K |
| 84443 Clinical Chemistry | Office | 1,350 | 679 | $16.39 | $22K |
| 80061 Clinical Chemistry | Office | 1,328 | 628 | $12.96 | $17K |
| 85025 Blood Count | Office | 1,280 | 694 | $7.57 | $9,692 |
| 84439 Clinical Chemistry | Office | 1,247 | 631 | $8.77 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 664 | 489 | $12.93 | $8,589 |
| 95251 Test - Miscellaneous | Office | 651 | 265 | $25.61 | $17K |
| 82306 Clinical Chemistry | Office | 353 | 310 | $28.63 | $10K |
| 83970 Clinical Chemistry | Office | 352 | 262 | $40.34 | $14K |
| 76536 Ultrasound - Nonspecific | Office | 295 | 286 | $75.40 | $22K |
| 82985 Clinical Chemistry | Office | 266 | 204 | $16.19 | $4,308 |
| 82570 Clinical Chemistry | Office | 253 | 238 | $4.97 | $1,257 |
By year: 2022 $427K for 20,355 services; 2023 $391K for 18,806 services; 2024 $582K for 21,608 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,102 | 897 | $5.85 | $12K |
| 80053 Clinical Chemistry | 1,737 | 812 | $10.27 | $18K |
| 83036 Blood Count | 1,534 | 707 | $9.41 | $14K |
| 84443 Clinical Chemistry | 1,350 | 679 | $16.39 | $22K |
| 80061 Clinical Chemistry | 1,328 | 628 | $12.96 | $17K |
| 85025 Blood Count | 1,280 | 694 | $7.57 | $9,692 |
| 84439 Clinical Chemistry | 1,247 | 631 | $8.77 | $11K |
| 82306 Clinical Chemistry | 353 | 310 | $28.63 | $10K |
| 83970 Clinical Chemistry | 352 | 262 | $40.34 | $14K |
| 82985 Clinical Chemistry | 266 | 204 | $16.19 | $4,308 |
Medicare prescription drug claims, 2024
In 2024, the drug Jacob Vadakekalam prescribed most often to Medicare patients was Levothyroxine Sodium, with 804 prescriptions and refills. In total Jacob Vadakekalam wrote 6,751 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 804 | 2,255 | 320 | $9,630 |
| Ozempic Semaglutide | 367 | 553 | 133 | $528K |
| Metformin Hcl Generic | 348 | 980 | 161 | $3,550 |
| Atorvastatin Calcium Generic | 344 | 996 | 169 | $3,600 |
| Rosuvastatin Calcium Generic | 335 | 947 | 165 | $4,504 |
| Mounjaro Tirzepatide | 304 | 395 | 96 | $405K |
| Glimepiride Generic | 227 | 650 | 119 | $1,723 |
| Metformin Hcl Er Metformin Hcl | 226 | 661 | 116 | $2,885 |
| Lisinopril Generic | 185 | 545 | 93 | $1,610 |
| Jardiance Empagliflozin | 182 | 454 | 91 | $260K |
| Farxiga Dapagliflozin Propanediol | 180 | 421 | 75 | $231K |
| Synthroid Levothyroxine Sodium | 133 | 336 | 47 | $11K |
| Losartan Potassium Generic | 118 | 344 | 59 | $981 |
| Trulicity Dulaglutide | 107 | 205 | 48 | $201K |
| V-Go 20 Sub-Q Insulin Device, 20 Unit | 104 | 122 | 37 | $62K |
Brand drugs: 2,745 claims; generic drugs: 3,554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacob Vadakekalam $7,093 ($7,093 in general payments such as food, travel and fees) from 33 companies. The largest payer was Senseonics, Incorporated with $2,800.
| Company | Payments | Amount |
|---|---|---|
| Senseonics, Incorporated SENS | 7 | $2,800 |
| Sequel Med Tech, LLC | 45 | $725 |
| Lilly USA, LLC LLY | 10 | $288 |
| Amgen Inc. AMGN | 18 | $280 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $252 |
| Sanofi-Aventis U.S. LLC SNY | 12 | $241 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $212 |
| Ascensia Diabetes Care Us Inc. | 14 | $210 |
| Novo Nordisk Inc NVO | 11 | $205 |
| Recordati_rare_diseases_inc. | 5 | $203 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.